
New FTI Consulting Survey Reveals Mounting Challenges Continue for U.S. Hospitals
WASHINGTON, May 15, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced findings from its annual Hospital Operations Outlook Survey of more than 200 senior executives across all types of hospitals. The survey found rising costs, patient wait times, workforce challenges and persistent cybersecurity threats are among the top issues highlighted by hospital leaders.
These issues — bundled with an increasingly complex operating environment shaped by regulatory changes, such as potential Medicaid cuts from the federal government, inflationary pressures and growing patient demand — make adaptability and nimbleness in an organization's ability to quickly respond to these challenges critical. Moreover, clear and strategic communications to stakeholders about the mounting pressures and plans to address them are more important than ever to maintain support inside and outside the hospital.
To protect their reputation and fulfill their mission, hospital leaders must stay closely connected with stakeholders while embracing value-based care, digital innovation, workforce investment and proactive cybersecurity risk mitigation as part of a broader strategic plan.
'Healthcare leaders are at a crossroads, juggling financial pressures with the need to deliver high-quality care, support hospital staff and improve patient outcomes,' said Lauren Crawford Shaver, Head of Healthcare & Life Sciences for the Americas within the Strategic Communications segment at FTI Consulting. 'At the same time, adaptation to the digital era demands investment in modern infrastructure, robust cybersecurity and AI-driven efficiencies. And with the regulatory landscape in constant flux, staying ahead requires more than strategy and vision. It takes agility to lead in a world that won't stand still.'
Key findings from the survey:
'Hospital executives are seeing promising, sustainable results when it comes to value-based care. This model is increasingly viewed as a smart, strategic approach in today's evolving healthcare environment given ongoing challenges such as market pressures and a shifting regulatory landscape,' said Paul Dioguardi, a Managing Director in FTI Consulting's Healthcare Risk Management & Advisory practice.
'In today's fast-evolving healthcare landscape, hospital leaders must make decisions that build resilient organizations,' said Rebecca Ayer Pitt, a Managing Director in FTI Consulting's Corporate Reputation practice within the Strategic Communications segment. 'This means investing in their workforce and value-based care as well as strengthening digital and cybersecurity capabilities. Most importantly, communicating proactively and transparently about strategic decisions and actions will build and maintain stakeholder confidence and support. In doing so, health systems will be better positioned to face the demands of the current healthcare environment without losing sight of what matters most — delivering exceptional care and patient outcomes.'
About the Survey
This research was conducted online by FTI Consulting's Strategic Communications segment between March 3, 2025 and March 12, 2025, with more than 200 senior executives across all types of hospitals and 17 mid-level leaders of academic hospitals. Overall, 60 respondents represent academic hospitals, 96 are part of a health system and 47 are hospitals not affiliated with health systems.
'FTI Consulting's Hospital Operations Outlook Survey offers healthcare leaders valuable insights into the headwinds and tailwinds being experienced by hospital and health system executives,' said James Condon, a Managing Director and Head of Research for the Americas in the Strategic Communications segment at FTI Consulting. 'The survey is designed to provide a holistic perspective on current industry pressures, and highlights innovative, forward-thinking, technology-driven solutions that are being leveraged by hospitals to adapt to and overcome these hardships.'
The full survey report is available here.
About FTI Consulting
FTI Consulting, Inc. is a leading global expert firm for organizations facing crisis and transformation, with more than 8,100 employees located in 33 countries and territories as of March 31, 2025. In certain jurisdictions, FTI Consulting's services are provided through distinct legal entities that are separately capitalized and independently managed. The Company generated $3.70 billion in revenues during fiscal year 2024. More information can be found at www.fticonsulting.com.
FTI Consulting, Inc.
555 12th Street NW
Washington, DC 20004
+1.202.312.9100
Investor Contact:
Mollie Hawkes
+1.617.747.1791
[email protected]
Media Contact:
Matthew Bashalany
+1.617.897.1545
[email protected]
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Bernstein Maintains a Market Perform Rating on Etsy (ETSY), Sets Price Target at $45
Bernstein SocGen Group maintained a Market Perform rating on Etsy, Inc. (NASDAQ:ETSY) with a price target of $45 on June 5. The analysts observed that growing investor confidence and potential short covering led Etsy shares to climb 32% since last month. A young woman shopping for a vintage fashion item online. Bernstein analysts noted that the upward momentum in Etsy, Inc. (NASDAQ:ETSY) stock is due to stronger alternative data indicating a slowdown in the annual decline of Gross Merchandise Sales in May. This data demonstrates an optimistic outlook for Etsy's growth, particularly compared to its prior lower trading multiples. The stock has gained significant ground, rising 16.15% over the last week and 16.37% so far this year. Although the main driver of this upward swing in the stock remains unclear, the analysts commented that lower traffic for Temu, an Etsy competitor, in May could be a catalyst. They also said that possible changes in products listed at Etsy could be behind this positive trajectory. The report pointed to stronger credit card spending in May and a rise in monthly app usage for Etsy, Inc. (NASDAQ:ETSY), which coincided with Temu witnessing a 43% drop in active users year-over-year. Although the analysts acknowledged that their data might not perfectly match Etsy's reported Gross Merchandise Sales, the overall signals suggest things are moving in a positive direction. Etsy, Inc. (NASDAQ:ETSY) runs global online marketplaces that bring together buyers and sellers through its main platform, Etsy, as well as Reverb for musical instruments and Depop for fashion resale. While we acknowledge the potential of ETSY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. Read Next: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29 minutes ago
- Yahoo
The Southern Company (SO) Upgraded at Jefferies on Promising Growth Prospects
Jefferies upgraded The Southern Company (NYSE:SO) to Buy from Hold on solid growth outlook, while adjusting the price target from $102 to $100 on June 5. According to the analysts, Southern Co.'s possible success in future requests for proposals (RFPs) could lead to considerable rate base growth, outperforming industry peers. A Southern Co. subsidiary, Georgia Power, is projected to obtain over 70% of an 8.5 gigawatt project, corresponding to nearly $12.9 billion in extra capital spending. A technician working with a control panel in a gas distribution center. Southern Co.'s earnings per share (EPS) are projected to climb at a compound annual growth rate (CAGR) of 7.2% until 2029, and increase to 7.9% through 2035, supported by the forecasted business growth. Analysts added that the regulatory environment is now stable given the settlement of a rate case, and financing is already underway, which limits execution risk. Jefferies reinforced the higher earnings potential at Southern Co. after 2027, which supports the rating adjustment despite the stock trading at a 15% premium. The Southern Company (NYSE:SO) operates as an integrated energy provider, managing electricity generation and natural gas distribution across major US markets. The company oversees extensive pipeline infrastructure and storage, caters to retail and wholesale customers, and provides advanced energy solutions like micro-grids and digital communications. While we acknowledge the potential of SO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
42 minutes ago
- Yahoo
HSBC Upgrades Dr. Reddy's Laboratories Limited (RDY) to Buy from Hold
On June 5, HSBC upgraded Dr. Reddy's Laboratories Limited (NYSE:RDY) from Buy to Hold, raising the price target to INR1,445 from INR1,235, citing an optimistic outlook for the company in terms of earnings potential and solid market standing. A worker at a biopharmaceutical facility packaging an active pharmaceutical ingredient. HSBC's updated estimates for FY2026 to FY2028 take into account the shifting market tide for semaglutide and gRevlimid. The analysts are waiting for semaglutide to be introduced in Canada, Brazil, and India at the beginning of FY2027, which is a greater leap from their prior hypothesis of a launch only in Canada by Q4 of FY2026. The analysts revised their FY2026 sales figures for Dr. Reddy's Laboratories Limited (NYSE:RDY)'s gRevlimid, noting the growing competition. The adjustment includes a 5.1% decrease in the EPS estimate for FY2026, while the EPS forecast for FY2027 and FY2028 grew by 12% to 13%. According to HSBC analysts, the expected surge in semaglutide sales will strengthen Dr. Reddy's earnings. HSBC assigned a new price target for RDY's American Depositary Receipts (ADR) as well, raising it from $14.44 to $16.90. Dr. Reddy's Laboratories Limited (NYSE:RDY) is a global pharma company based in Hyderabad, India, that makes both branded and generic medicines for a wide range of health conditions. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. While we acknowledge the potential of RDY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data